These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21172065)

  • 1. Altered glycosylation profile of purified plasma ACT from Alzheimer's disease.
    Ianni M; Manerba M; Di Stefano G; Porcellini E; Chiappelli M; Carbone I; Licastro F
    Immun Ageing; 2010 Dec; 7 Suppl 1(Suppl 1):S6. PubMed ID: 21172065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairment.
    Lundström SL; Yang H; Lyutvinskiy Y; Rutishauser D; Herukka SK; Soininen H; Zubarev RA
    J Alzheimers Dis; 2014; 38(3):567-79. PubMed ID: 24028868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.
    Porcellini E; Davis EJ; Chiappelli M; Ianni E; Di Stefano G; Forti P; Ravaglia G; Licastro F
    Curr Pharm Des; 2008; 14(26):2659-64. PubMed ID: 18991685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-glycan profile in cortex and hippocampus is altered in Alzheimer disease.
    Gaunitz S; Tjernberg LO; Schedin-Weiss S
    J Neurochem; 2021 Oct; 159(2):292-304. PubMed ID: 32986846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
    Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycan and Alzheimer's disease.
    Kizuka Y; Kitazume S; Taniguchi N
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
    Licastro F; Pedrini S; Caputo L; Annoni G; Davis LJ; Ferri C; Casadei V; Grimaldi LM
    J Neuroimmunol; 2000 Feb; 103(1):97-102. PubMed ID: 10674995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
    Di Domenico F; Owen JB; Sultana R; Sowell RA; Perluigi M; Cini C; Cai J; Pierce WM; Butterfield DA
    J Neurosci Res; 2010 Dec; 88(16):3566-77. PubMed ID: 20936705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Brain and Blood N-Glycome Profiling in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
    Yu L; Huo Z; Yang J; Palma-Gudiel H; Boyle PA; Schneider JA; Bennett DA; Zhao J
    Front Aging Neurosci; 2021; 13():765259. PubMed ID: 34776937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease.
    Licastro F; Sirri V; Trerè D; Davis LJ
    Dement Geriatr Cogn Disord; 1997; 8(6):337-42. PubMed ID: 9370085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF N-glycoproteomics for early diagnosis in Alzheimer's disease.
    Palmigiano A; Barone R; Sturiale L; Sanfilippo C; Bua RO; Romeo DA; Messina A; Capuana ML; Maci T; Le Pira F; Zappia M; Garozzo D
    J Proteomics; 2016 Jan; 131():29-37. PubMed ID: 26455811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes.
    Scacchi R; Ruggeri M; Gambina G; Martini MC; Ferrari G; Corbo RM
    Neurobiol Aging; 2001; 22(3):413-6. PubMed ID: 11378247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.
    Faid V; Evjen G; Tollersrud OK; Michalski JC; Morelle W
    Glycobiology; 2006 May; 16(5):440-61. PubMed ID: 16449350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.
    Lee SM; Booe JM; Gingell JJ; Sjoelund V; Hay DL; Pioszak AA
    Biochemistry; 2017 Jul; 56(26):3380-3393. PubMed ID: 28614667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer's Disease Brain.
    Suttapitugsakul S; Stavenhagen K; Donskaya S; Bennett DA; Mealer RG; Seyfried NT; Cummings RD
    Mol Cell Proteomics; 2022 Dec; 21(12):100433. PubMed ID: 36309312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
    Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
    Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.